The development of biomarkers for the prediction of lymph node metastasis and prognosis is critical for deciding the treatment modality of tongue cancer. The purpose of our study is to investigate the clinical implications of epithelial-mesenchymal transition (EMT) expression in tongue cancer.
Study Design
Historical cohort study
Setting
Tertiary-care hospital.
Subjects and Methods
The study included 95 subjects with tongue cancer who underwent wide excision and neck dissection. According to characteristics of immunohistochemical staining for E-cadherin and vimentin, we classified the tumors as complete EMT phenotype, incomplete EMT phenotype, or epithelial phenotype. The correlation between risk factors and nodal metastasis was assessed, and disease-free survival (DFS) was analyzed.
Results
Positive lymph nodes were detected in 46 (48.4%) patients and was found to correlate significantly with depth of invasion ≥4 mm and EMT expression on multivariate analysis (P = .030, P = .022, respectively). The mean follow-up period of all patients was 96.3 months (range, 6-149 months). Overall 5-year DFS was 61.7%. On multivariate analysis, the only factors affecting DFS were nodal stage and EMT expression (P = .033, P = .021, respectively).
Conclusions
Our study reveals that EMT expression is a significant biomarker for predicting lymph node metastasis and tumor recurrence in tongue cancer. Evaluation of EMT expression in tongue cancer can allow therapy to be offered accordingly.
AmbroschPKronMPradierO. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001;124:180-187.
2.
HuangSFKangCJLinCY. Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer. 2008;112:1066-1075.
3.
D’CruzAKSiddachariRCWalvekarRR. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck. 2009;31:618-624.
4.
ZhengMLiLTangYL. Biomarkers in tongue cancer: understanding the molecular basis and their clinical implications. Postgrad Med J. 2010;86:292-298.
5.
FaustinoSEOliveiraDTNonogakiS. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2008;37:372-378.
6.
NatoriTKogaMAnegawaE. Usefulness of intra-oral ultrasonography to predict neck metastasis in patients with tongue carcinoma. Oral Dis. 2008;14:591-599.
7.
ChungMKJeongHSSonYI. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Ann Surg Oncol. 2009;16:3111-3117.
8.
JungJChoNHKimJ. Significant invasion depth of early oral tongue cancer originated from the lateral border to predict regional metastases and prognosis. Int J Oral Maxillofac Surg. 2009;38:653-660.
9.
KaurGCarnelioSRaoN. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study. Indian J Dent Res. 2009;20:71-76.
10.
Mark TaylorSDroverCMaceachernR. Is preoperative ultrasonography accurate in measuring tumor thickness and predicting the incidence of cervical metastasis in oral cancer?Oral Oncol. 2010;46:38-41.
11.
El-NaajIALeiserYShveisM. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg. 2011;69:2674-2679.
12.
YangTLLouPJChangYL. Tumor satellite in predicting occult nodal metastasis of tongue cancer. Otolaryngol Head Neck Surg. 2011;145:599-605.
13.
JooYHJungCKKimMS. Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer. Otolaryngol Head Neck Surg. 2009;140:512-518.
14.
KeumKCChungEJKoomWS. Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer. Otolaryngol Head Neck Surg. 2006;135:858-864.
15.
HuberGFZulligLSoltermannA. Down regulation of E-Cadherin (ECAD)—a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer. 2011;11:217:1-8.
16.
IwatsukiMMimoriKYokoboriT. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293-299.
17.
NijkampMMSpanPNHoogsteenIJ. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99:344-348.
18.
LiuLKJiangXYZhouXX. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol. 2010;23:213-224.
19.
GeorgoliosAEleftheriadouABatistatouA. Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer. Med Oncol. 2012;29:1463-1467.
20.
SmithATeknosTNPanQ. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol. 2013;49:287-292.
FerreiraMBDe SouzaJACohenEE. Role of molecular markers in the management of head and neck cancers. Curr Opin Oncol. 2011;23:259-264.
23.
MandalMMyersJNLippmanSM. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008;112:2088-2100.
24.
FoschiniMPCocchiRMorandiL. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Head Neck. 2008;30:1475-1482.
25.
PyoSWHashimotoMKimYS. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg. 2007;35:1-9.
26.
NakanishiYAkimotoSSatoY. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol. 2004;12:323-328.
27.
HungKFChangCSLiuCJ. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med. 2006;35:589-594.
28.
DingLZhangZShangD. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma. J Oral Pathol Med. 2014;43:335-343.
29.
WarburtonGNikitakisNGRobersonP. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg. 2007;65:475-484.
30.
MostaanLVKhorsandiMTSharifianSM. Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not. Pathol Res Pract. 2011;207:448-451.
31.
FukanoHMatsuuraHHasegawaY. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck. 1997;19:205-210.
32.
PenteneroMGandolfoSCarrozzoM. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck. 2005;27:1080-1091.
33.
MelchersLJSchuuringEvan DijkBA. Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol. 2012;48:337-342.
34.
KurokawaHYamashitaYTakedaS. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck. 2002;24:731-736.
35.
GomesLRTerraLFSogayarMC. Epithelial-mesenchymal transition: implications in cancer progression and metastasis. Curr Pharm Biotechnol2011;12:1881-1890.
36.
VeredMAllonIBuchnerA. E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression. Histol Histopathol. 2012;27:141-150.
37.
PectasidesERampiasTSasakiC. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC). PLoS One. 2014;9:e94273.
38.
RosadoPLequerica-FernandezPFernandezS. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Br J Oral Maxillofac Surg. 2013;51:149-156.
